Bio-IT World January 20, 2026
Pistoia Alliance survey reveals industry shift from efficiency gains to innovation, while data readiness remains top obstacle
The pharmaceutical industry’s approach to artificial intelligence is maturing, with companies increasingly focused on innovation rather than mere efficiency gains, according to Christian Baber, Chief Portfolio Officer at the Pistoia Alliance. However, significant hurdles around data quality and workforce training continue to impede progress.
Speaking about findings from the Alliance’s “Lab of the Future” survey last fall and more recent conference polling at the Pistoia Alliance Boston event, Baber noted a surprising silver lining in what might initially appear as concerning statistics. When survey results showed that approximately 27% of respondents didn’t know the source of data used...
Today's Sponsors
Today's Sponsor